13 results
DEFM14A
AGIO
Agios Pharmaceuticals Inc
11 Feb 21
Proxy related to merger
4:19pm
to attract and retain talent and encourage employees to innovate in its genetically defined disease business because equity performance will be more aligned
PREM14A
fwdq0crfbarq1
29 Jan 21
Preliminary proxy related to merger
4:22pm
DEFA14A
mo856monw9ow
23 Dec 20
Additional proxy soliciting materials
4:52pm
DEFA14A
EX-99.1
59v58klvpxs5r d3
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.1
rgw36ycvvtf01skrr
21 Dec 20
Regulation FD Disclosure
7:04am
8-K
xeg07 9d4jq7
10 Dec 14
Departure of Directors or Certain Officers
12:00am
DEF 14A
75147t6lk6uu4kql6e
7 Apr 14
Definitive proxy
12:00am
- Prev
- 1
- Next